Molecular analysis of mutations in DNA polymerase η in xeroderma pigmentosum-variant patients

Broughton, Bernard C, Cordonnier, Agnes, Kleijer, Wim J, Jaspers, Nicolaas G J, Fawcett, Heather, Raams, Heather, Garritsen, Victor H., Stary, Anne, Avril, Marie-Francoise, Boudsocq, Francois, Masutani, Chikahide, Hanaoka, Fumio, Fuchs, Robert P, Sarasin, Alain and Lehmann, Alan R (2002) Molecular analysis of mutations in DNA polymerase η in xeroderma pigmentosum-variant patients. Proceedings of the National Academy of Sciences of the United States of America, 99 (2). pp. 815-820. ISSN 1091-6490

Full text not available from this repository.


Xeroderma pigmentosum variant (XP-V) cells are deficient in their ability to synthesize intact daughter DNA strands after UV irradiation. This deficiency results from mutations in the gene encoding DNA polymerase eta, which is required for effecting translesion synthesis (TLS) past UV photoproducts. We have developed a simple cellular procedure to identify XP-V cell strains, and have subsequently analyzed the mutations in 21 patients with XP-V. The 16 mutations that we have identified fall into three categories. Many of them result in severe truncations of the protein and are effectively null alleles. However, we have also identified five missense mutations located in the conserved catalytic domain of the protein. Extracts of cells falling into these two categories are defective in the ability to carry out TLS past sites of DNA damage. Three mutations cause truncations at the C terminus such that the catalytic domains are intact, and extracts from these cells are able to carry out TLS. From our previous work, however, we anticipate that protein in these cells will not be localized in the nucleus nor will it be relocalized into replication foci during DNA replication. The spectrum of both missense and truncating mutations is markedly skewed toward the N-terminal half of the protein. Two of the missense mutations are predicted to affect the interaction with DNA, the others are likely to disrupt the three-dimensional structure of the protein. There is a wide variability in clinical features among patients, which is not obviously related to the site or type of mutation.

Item Type: Article
Additional Information: GDSC11
Schools and Departments: School of Life Sciences > Sussex Centre for Genome Damage and Stability
Subjects: Q Science > Q Science (General)
Depositing User: Gee Wheatley
Date Deposited: 17 May 2007
Last Modified: 13 Jun 2013 14:06
📧 Request an update